Invention Grant
- Patent Title: Plasmid constructs for heterologous protein expression and methods of use
-
Application No.: US16062983Application Date: 2016-12-16
-
Publication No.: US11713467B2Publication Date: 2023-08-01
- Inventor: Jean Campbell , David A. Canton , Robert H. Pierce
- Applicant: OncoSec Medical Incorporated
- Applicant Address: US NJ Pennington
- Assignee: OncoSec Medical Incorporated
- Current Assignee: OncoSec Medical Incorporated
- Current Assignee Address: US NJ Ewing
- Agency: Procopio, Cory Hargreaves & Savitch LLP
- International Application: PCT/US2016/067388 2016.12.16
- International Announcement: WO2017/106795A 2017.06.22
- Date entered country: 2018-06-15
- Main IPC: C12N15/85
- IPC: C12N15/85 ; C07K14/54 ; C07K14/52 ; C07K14/715 ; A61K9/00 ; A61P35/00 ; C07K14/57 ; G01N33/574

Abstract:
Provided are plasmid vector constructs encoding multiple immunomodulatory proteins where each protein or component thereof can be expressed utilizing appropriate promotors and/or translation modifiers. Additional immunomodulatory proteins and genetic adjuvants containing shared tumor antigens can be added to further therapeutic potential as well as allow tracking of therapeutic treatment. Also provides are methods of expressing the plasmid constructs.
Public/Granted literature
- US20190153469A1 Plasmid Constructs For Heterologous Protein Expression And Methods Of Use Public/Granted day:2019-05-23
Information query
IPC分类: